Comment from American Veterinary Medical Association (AVMA)

AnonymousSupportAdvocacy
Summary: The American Association of Feline Practitioners (AAFP) and the American Veterinary Medical Association (AVMA) are submitting nominations to add GC 376 and GS-441524 to the list of bulk drug substances for compounding office stock drugs. They argue that these substances are necessary for the urgent treatment of Feline Infectious Peritonitis (FIP) due to limited access to approved alternatives and the need for immediate treatment to prevent animal suffering.
Please see the attached nomination materials from AVMA for GC376 and GS 441524. Thank you.

View on Regulations.gov